Citadel Advisors’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Citadel Advisors’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,200	Closed	-$42K	–	14896
2022 Q1	$42K	Buy	14,200 +2,600	+22%	+$5.72K	﹤0.01%	12917
2021 Q4	$15K	Sell	11,600 -3,500	-23%	-$7.01K	﹤0.01%	13632
2021 Q3	$34K	Buy	15,100 +2,600	+21%	+$9.34K	﹤0.01%	13536
2021 Q2	$71K	Buy	12,500 +600	+5%	+$3.99K	﹤0.01%	13161
2021 Q1	$75K	Buy	+11,900	New	+$89.3K	﹤0.01%	12699

Citadel Advisors's TLMD Position: Q3 2021 in Review

Citadel Advisors sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q3 2021, closing a stake of 70,360 shares — an estimated $253K sold.

Citadel Advisors first reported a position in TLMD in Q1 2021 and held it in 2 quarters. The position peaked at $1.17M in Q1 2021. 64 funds tracked by Wall St. Rank hold TLMD as of Q3 2021.

Citadel Advisors reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q3 2021 after selling out during the quarter.
Citadel Advisors sold 70,360 SOC Telemed, Inc. Class A Common Stock shares in Q3 2021, an estimated $253K.
Citadel Advisors first reported a position in SOC Telemed, Inc. Class A Common Stock in Q1 2021 and held it in 2 quarters.
Citadel Advisors's SOC Telemed, Inc. Class A Common Stock position peaked at $1.17M in Q1 2021.
64 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q3 2021.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.